Neumora Therapeutics (NMRA) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Neumora Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $15.0M and 4 sold $1.1M of NMRA stock on the open market, including a cluster buy that began Oct 27, 2025.
Get emailed when insiders cluster-buy stocks like NMRA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NMRA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $701K | 11 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $83K | 4 |
| Q4 2025 | $15.0M | 3 | $307K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 Neumora Therapeutics, Inc. insiders reported open-market purchases totaling $15.0M, while 4 insiders reported sales totaling $1.1M. The most recent cluster buy began on Oct 27, 2025, when 3 insiders bought a combined $15.0M. Among insiders with enough purchase history to measure, Paul L Berns (See Remarks) has the highest Insider Score at 4. 2 of 16 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 21SEC | Daljit Singh AuroraSee Remarks | Sell | 67,74148,750 held (−58%) | $1.51 | $102K | -68.5% | — |
| Aug 21SEC | Daljit Singh AuroraSee Remarks | Sell | 66,711 | $1.51 | $101K | -68.5% | — |
| Aug 21SEC | Daljit Singh AuroraSee Remarks | Sell | 21,055 | $1.60 | $34K | -70.2% | — |
| Aug 21SEC | Daljit Singh AuroraSee Remarks | Sell | 20,55348,750 held (−30%) | $1.59 | $33K | -70.1% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 57,67082,770 held (−41%) | $1.51 | $87K | -68.5% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 55,016 | $1.50 | $83K | -68.3% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 34,987 | $1.59 | $56K | -70.1% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 34,16248,750 held (−41%) | $1.58 | $54K | -69.9% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 31,00048,750 held (−39%) | $1.65 | $51K | -71.2% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 30,918 | $1.65 | $51K | -71.2% | — |
| Aug 19SEC | Daljit Singh AuroraSee Remarks | Sell | 34,02048,750 held (−41%) | $1.49 | $51K | -68.1% | — |
| Feb 19SEC | Paul L BernsSee Remarks | Sell | 9,8197,395,185 held (−0%) | $3.51 | $34K | -86.4% | 4 |
| Feb 19SEC | Daljit Singh AuroraSee Remarks | Sell | 6,16582,770 held (−7%) | $3.56 | $22K | -86.6% | — |
| Feb 19SEC | Joshua PintoPresident | Sell | 5,96757,783 held (−9%) | $3.54 | $21K | -86.6% | — |
| Feb 19SEC | Michael Lee MilliganSee Remarks | Sell Plan | 1,43621,034 held (−6%) | $3.57 | $5K | -86.7% | — |
| Nov 13SEC | Daljit Singh AuroraSee Remarks | Sell Plan | 114,703 | $2.68 | $307K | -82.2% | — |
| Oct 29SEC | Arch Venture Partners Viii, Llc10% Owner | Buy | 1,915,7006,046,907 held (+46%) | $2.61 | $5.0M | -81.8% | — |
| Oct 29SEC | Arch Venture Partners Xii, Llc10% Owner | Buy | 1,915,7006,046,907 held (+46%) | $2.61 | $5.0M | -81.8% | — |
| Oct 29SEC | Kristina BurowDirector | Buy | 1,915,7006,046,907 held (+46%) | $2.61 | $5.0M | -81.8% | — |
Insiders at Neumora Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Arch Venture Partners Viii, Llc10% Owner | $5.0M | — | Oct 29, 2025 | — |
| Arch Venture Partners Xii, Llc10% Owner | $5.0M | — | Oct 29, 2025 | — |
| Kristina BurowDirector | $5.0M | — | Oct 29, 2025 | — |
| Daljit Singh AuroraSee Remarks | — | $1.0M | Aug 21, 2026 | — |
| Paul L BernsSee Remarks | — | $34K | Feb 19, 2026 | 4 |
| Joshua PintoPresident | — | $21K | Feb 19, 2026 | — |
| Michael Lee MilliganSee Remarks | — | $5K | Feb 19, 2026 | — |
NMRA stock: common questions
Are Neumora Therapeutics, Inc. insiders buying NMRA stock?
In the past 12 months, 3 insiders reported open-market purchases of NMRA worth $15.0M. The latest was 10% Owner Arch Venture Partners Viii, Llc bought $5.0M of NMRA at $2.61 — first open-market purchase in our records; raises the stake by 46%.
Are Neumora Therapeutics, Inc. insiders selling NMRA stock?
4 insiders reported sales worth $1.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NMRA's 52-week range?
Over the past year NMRA has traded between $0.47 and $3.59. It last closed at $0.48 on Oct 9, 2026.